1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow flumatinib: new trials by email Literature Review of flumatinib trials Research Report on flumatinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Azacitidine,Venetoclax,and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients Azacitidine, Venetoclax, Flumatinib - Philadelphia Chromosome, Acute Myeloid Leukemia | Phase 2 | Completed | The First Affiliated Hospital of Soochow University | 20 | 2022-05-01 | 2024-04-25 |
| A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia flumatinib, imatinib - Myelogenous Leukemia, Chronic | Phase 2 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 150 | 2011-08-01 | 2013-04-10 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Philadelphia Chromosome (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Jiangsu HengRui Medicine Co., Ltd. (1) · The First Affiliated Hospital of Soochow University (1)
China (2)
Fengkui Zhang, Dr. (1) · Jianxiang Wang, Dr. (1) · Xiaowen Tang, Ph.D (1)